Integrated Analytical Solutions, Inc.
GD3

You will now be redirected to the GD3 website

Integrated Analytical Solutions, Inc. is a proud member of Genesis Drug Discovery & Development (GD3), a fully integrated CRO providing services to support drug discovery programs of our clients from target discovery through IND filing and managing Phase I-III clinical trials.

Learn more about GD3
Search

SERVICES

Mycotoxin

Cannabinoid Service

Specimens:

Fresh, dried, or infused cannabis flowers and oils

Detection Method:

Shimadzu/Sciex High-performance Liquid Chromatography with Tandem Mass Spectrometry (LC-MS/MS)

Detection Limit:

Parts per billion (ppb)

Mycotoxins are toxic substances produced by molds and fungi. These harmful compounds can contaminate cannabis plants at various stages of growth, harvest, and processing. Warm, humid conditions are ideal for cannabis cultivation, and they also provide a perfect environment for mold and fungi to thrive.

Why is Mycotoxin Contamination a Concern?

Mycotoxins pose significant health risks, especially for immunocompromised individuals. When ingested or inhaled, contaminated cannabis products can lead to:

  • Acute health issues: Nausea, vomiting, abdominal pain, and liver damage.
  • Long-term health risks: Increased risk of cancer, particularly liver cancer and kidney damage.

Common Mycotoxins in Cannabis

  • Aflatoxins: Produced by Aspergillus flavus and Aspergillus parasiticus, aflatoxins are highly carcinogenic. Exposure can lead to acute liver injury and significantly increase the risk of liver cancer.
  • Ochratoxin A: Produced by certain Aspergillus and Penicillium species, ochratoxin A can damage the kidneys and liver.

State of New Jersey accepted detection limits are:

per billion (ppb)
Aflatoxin B1 20 ppb
Aflatoxin B2 20 ppb
Aflatoxin G1 20 ppb
Aflatoxin G2 20 ppb
Ochratoxin A 20 ppb
Start Testing Now!